Do antibiotic-impregnated catheters prevent infection in CSF diversion procedures? Review of the literature

被引:44
作者
Gutierrez-Gonzalez, Raquel [1 ]
Boto, Gregorio R. [1 ]
机构
[1] Hosp Univ Clin San Carlos, Dept Neurosurg, Madrid 28040, Spain
关键词
Antibiotic-impregnated; Catheter; Cerebrospinal fluid; External ventricular drain; Infection; Shunt; CEREBROSPINAL-FLUID SHUNT; CENTRAL VENOUS CATHETERS; VENTRICULAR DRAIN CATHETERS; IN-VIVO EFFICACY; INTRAVENTRICULAR CATHETERS; SILVER NANOPARTICLES; SILICONE CATHETERS; RIFAMPIN; VITRO; COLONIZATION;
D O I
10.1016/j.jinf.2010.03.030
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Cerebrospinal fluid shunting devices are foreign bodies internally or externally placed in a patient with the aim of improving the prognosis. Device-related infection is the most serious complication. Its importance arises from the high frequency of occurrence and the consequences that it implies in terms of morbidity and mortality. As a result, the presence of these two factors increases significantly hospital costs. Among many primary prevention measures investigated, one of those that has gained in importance over the last years is the use of antibiotic-impregnated catheters. Although their experimental development dates back to the 1970s, experience in clinical practice has not been settled until the last decade. This is the reason why only 22 studies on the usefulness of AICs in CSF shunting procedures in clinical practice have been published in the literature since their commercialization. Although experience with antibiotic-impregnated shunts continues growing, practice with antibiotic-impregnated external ventricular drains is much shorter. The present study reviews and analyses the different investigations performed in order to determine the efficacy of antibiotic-impregnated shunts and external ventricular drains with the aim of reducing device-related infectious complications. The results suggest that AICs reduce device-related infection as well as hospital costs. However, evidence is not enough to state categorical conclusions, and further large, prospective, randomized and double-blind studies must be performed in order to confirm these results and the efficacy of other antibiotic-impregnated devices. Further economic evaluation is required to confirm the benefit in terms of cost-effectiveness as well. (c) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:9 / 20
页数:12
相关论文
共 73 条
[1]   AN EVALUATION OF THE EPILEPTOGENIC PROPERTIES OF A RIFAMPICIN CLINDAMYCIN-IMPREGNATED SHUNT CATHETER [J].
ABED, WT ;
ALAVIJEH, MS ;
BAYSTON, R ;
SHORVON, SD ;
PATSALOS, PN .
BRITISH JOURNAL OF NEUROSURGERY, 1994, 8 (06) :725-730
[2]   Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection [J].
Albanese, Alessio ;
De Bonis, Pasquale ;
Sabatino, Giovanni ;
Capone, Gennaro ;
Marchese, Enrico ;
Vignati, Andrea ;
Maira, Giulio .
ACTA NEUROCHIRURGICA, 2009, 151 (10) :1259-1263
[3]   Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children [J].
Aryan, HE ;
Meltzer, HS ;
Park, MS ;
Bennett, RL ;
Jandial, R ;
Levy, ML .
CHILDS NERVOUS SYSTEM, 2005, 21 (01) :56-61
[4]   Hospital Costs Associated With Shunt Infections in Patients Receiving Antibiotic-Impregnated Shunt Catheters Versus Standard Shunt Catheters [J].
Attenello, Frank J. ;
Garces-Ambrossi, Giannina L. ;
Zaidi, Hasan A. ;
Sciubba, Daniel M. ;
Jallo, George I. .
NEUROSURGERY, 2010, 66 (02) :284-289
[5]   PREVENTION OF CATHETER-RELATED INFECTIONS BY ANTISEPTIC BONDING [J].
BACH, A ;
BOHRER, H ;
MOTSCH, J ;
MARTIN, E ;
GEISS, HK ;
SONNTAG, HG .
JOURNAL OF SURGICAL RESEARCH, 1993, 55 (06) :640-646
[6]  
BAYSTON R, 1988, MED LAB SCI, V45, P235
[7]   ANTI-MICROBIAL ACTIVITY OF SILICONE-RUBBER USED IN HYDROCEPHALUS SHUNTS, AFTER IMPREGNATION WITH ANTI-MICROBIAL SUBSTANCES [J].
BAYSTON, R ;
MILNER, RDG .
JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (09) :1057-1062
[8]   PREVENTION OF HYDROCEPHALUS SHUNT CATHETER COLONIZATION INVITRO BY IMPREGNATION WITH ANTIMICROBIALS [J].
BAYSTON, R ;
GROVE, N ;
SIEGEL, J ;
LAWELLIN, D ;
BARSHAM, S .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (05) :605-609
[9]  
BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25
[10]   Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts [J].
Bayston, R ;
Ashraf, W ;
Bhundia, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :778-782